BT
PRCT icon

Banque Transatlantique’s Procept Biorobotics PRCT Stock Holding History

Banque Transatlantique’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Hold
118,436
– – 0.06% 100
2026
Q1 		$2.96M Buy
+118,436
New +$3.34M 0.07% 78

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Banque Transatlantique's PRCT Position: Q2 2026 in Review

Banque Transatlantique held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 118,436 shares worth $2.67M. The position accounts for 0.06% of the portfolio, ranked #100.

Banque Transatlantique first reported a position in PRCT in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.96M in Q1 2026. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Banque Transatlantique held 118,436 shares of Procept Biorobotics worth $2.67M as of Q2 2026.
  • Banque Transatlantique left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up 0.06% of Banque Transatlantique's portfolio in Q2 2026, its #100 holding.
  • Banque Transatlantique first reported a position in Procept Biorobotics in Q1 2026 and has held it in 2 quarters since.
  • Banque Transatlantique's Procept Biorobotics position peaked at $2.96M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.